Chunlizhengda (Stock Code: 1858) Announces Extraordinary General Meeting and Proxy Form Details

Bulletin Express10-31

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) has issued a proxy form for its Extraordinary General Meeting, scheduled for 19 November 2025 at 2:00 p.m. The meeting will take place at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC.

According to the announcement, shareholders may appoint the Chairman of the meeting or another proxy to vote on several proposed resolutions. The proposals include abolishing the Supervisory Committee and amending the Articles of Association, revising the Rules of Procedures for both General Meetings and Board Meetings, updating the Working System for Independent Directors, reviewing amendments to the Management Measures for Use of Proceeds, and considering the 2025 Third Quarterly Profit Distribution Plan.

The circular dated 30 October 2025 provides further specifics on these items. Shareholders who intend to vote by proxy are advised to complete the provided documentation and submit it at least 24 hours before the meeting. The announcement also notes that attending shareholders and proxies must present valid identification. Completion of the proxy form does not preclude registration and voting in person. Shareholders with any questions may refer to the original notice or contact the designated share registrar for more information.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment